Literature DB >> 955676

Studies on the interaction of the Sophora japonica lectin and concanavalin A with erythrocytes and lymphocytes.

R D Poretz, R F Barth.   

Abstract

The agglutinating activity of lectins from the seeds of Sophora japonica and Canavalia ensiformis (concanavalin A) with human and murine erythrocytes and lymphocytes have been compared to one another and related to the mitogenic and immunosuppressive properties of these purified proteins. The S. japonica lectin, which demonstrates blood group specificity, is more active than concanavalin A with human erythrocytes, but has a much lower reactivity than concanavalin A with murine red blood cells. Ficin treatment of human erythrocytes results in an increase in agglutinability by both lectins as well as causing the appearance of S. japonica lectin receptors on type O cells. Treatment of murine reythrocytes with ficin alone or followed by beta-galactosidase causes the cells to be more reactive with concanavalin A. Beta-Galactosidase alone has no observable affect on the cells. In contrast, the agglutinability of cells by the S. japonica lectin increases after ficin treatment but is not affected by beta-galaetosidose treatment either after or in the absence of ficinization. Murine lymphocytes react with both lectins in a manner paralleling the agglutination patterns of murine erythrocytes. The S. japonica lectin appears to be devoid of mitogenic and immuno-suppressive activity, in contrast to concanavalin A which suppresses the T helper-dependent antibody response to sheep erythrocytes. These results are discussed in terms of the types of lectin receptors on lymphocytes related to agglutination, induction of blastogenesis and immuno-suppression.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 955676      PMCID: PMC1445108     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  26 in total

1.  Binding of Maclura pomifera lectin to rat lymphoid cells and erythrocytes.

Authors:  J M Jones; J D Feldman
Journal:  J Immunol       Date:  1973-12       Impact factor: 5.422

2.  Differential effects of concanavalin A on T helper dependent and independent antibody responses.

Authors:  R F Barth; O Singla
Journal:  Cell Immunol       Date:  1973-10       Impact factor: 4.868

3.  Studies on heterologous antilymphocyte and antithymocyte sera. IV. Further evidence for a preferential effect on antigen-sensitive cells.

Authors:  R F Barth
Journal:  J Immunol       Date:  1969-10       Impact factor: 5.422

4.  Immunochemical studies on blood groups. LVI. Purification of glycoproteins with different I determinants from hydatid cyst fluid and from human milk on insoluble anti-I immunoadsorbents.

Authors:  T Feizi; E A Kabat
Journal:  J Immunol       Date:  1974-01       Impact factor: 5.422

5.  Immunochemical studies on blood groups. LIV. Classification of anti-I and anti-i sera into groups based on reactivity patterns with various antigens related to the blood group A,B,H, Le a, Le b and precursor substances.

Authors:  T Feizi; E A Kabat
Journal:  J Exp Med       Date:  1972-06-01       Impact factor: 14.307

6.  Unmasking of xenogeneic neo-antigens on mouse lymphoid cell surfaces by Vibrio cholerae neuraminidase.

Authors:  P K Ray; R L Simmons
Journal:  Proc Soc Exp Biol Med       Date:  1973-01

7.  Antigens of the Ii system on lymphocytes.

Authors:  K H Shumak; R A Rachkewich; M C Crookston; J H Crookston
Journal:  Nat New Biol       Date:  1971-06-02

8.  Purification and properties of the hemagglutinin from Sophora japonica seeds.

Authors:  R D Poretz; H Riss; J W Timberlake; S M Chien
Journal:  Biochemistry       Date:  1974-01-15       Impact factor: 3.162

9.  The anti-I activity of the Sophora japonica lectin.

Authors:  T Lemanski; R D Poretz
Journal:  Immunochemistry       Date:  1974-08

10.  Interaction of the carbohydrate-binding protein concanavalin A with normal and transformed cells.

Authors:  M Inbar; L Sachs
Journal:  Proc Natl Acad Sci U S A       Date:  1969-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.